AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24028546 — intervention group
Group type: COMPARATOR
Intervention: 11 weeks delay between RCT and surgery
Number of subjects: 264
Study 21385641 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss maintainers (WLM)
Number of subjects: 287
Study 19409159 — intervention group
Group type: EXPERIMENTAL
Intervention: Band ligation plus propranolol and nitrate
Number of subjects: 160
Study 19409159 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol plus isosorbide mononitrate
Number of subjects: 160
Study 19409159 — intervention group
Group type: EXPERIMENTAL
Intervention: Band ligation
Number of subjects: 160
Study 19409159 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 160
Study 17679135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid clinic (n=617)
Number of subjects: 1233
Study 17679135 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=616)
Number of subjects: 1233
Study 15165918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 58
Study 15165918 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 58
Study 15165918 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 58
Study 15165918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 11524897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 0
Study 11524897 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 0
Study 11524897 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial interventions
Number of subjects: 0
Study 9735580 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy with initial weight loss
Number of subjects: 130
Study 9735580 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy with weight-loss goals
Number of subjects: 130
Study 9735580 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy with achieved weight goals
Number of subjects: 130
Study 9735580 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 130
Study 7817735 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical abortion (mifepristone 600 mg followed 48 h later by gemeprost 1 mg vaginal pessary)
Number of subjects: 363
Study 7817735 — intervention group
Group type: COMPARATOR
Intervention: Surgical vacuum aspiration under general anesthesia
Number of subjects: 363
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg ampicillin orally every 6 hours for 10 days
Number of subjects: 150
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg erythromycin orally every 6 hours for 10 days
Number of subjects: 150
Study 3186088 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotics)
Number of subjects: 150
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive amniotic fluid cultures
Number of subjects: 150
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative amniotic fluid cultures
Number of subjects: 150
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic chorioamnionitis in negative cultures
Number of subjects: 150
Study 3186088 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical colonization with group B streptococcus and/or Gardnerella vaginalis
Number of subjects: 150
Study 51533 — intervention group
Group type: EXPERIMENTAL
Intervention: Candicidin therapy
Number of subjects: 0
Study 51533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31530204 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer assessment platform of clinical skills (Year 2013 students)
Number of subjects: 252
Study 31530204 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (Year 2012 students)
Number of subjects: 252
Study 28323989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 1228
Study 28323989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1228
Study 25474502 — intervention group
Group type: EXPERIMENTAL
Intervention: Core-Stability (CS) exercises plus myofascial trigger-point (MTrP) therapy
Number of subjects: 10
Study 25474502 — intervention group
Group type: COMPARATOR
Intervention: Core-Stability (CS) exercises alone
Number of subjects: 10
Study 23299139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) using calf-thigh-length IPC in both legs (SCD Express)
Number of subjects: 56
Study 23299139 — intervention group
Group type: COMPARATOR
Intervention: No IPC (control group)
Number of subjects: 56
Study 21624223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (HD-DXM)
Number of subjects: 59
Study 21624223 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 59
Study 18424874 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential treatment
Number of subjects: 0
Study 18424874 — intervention group
Group type: COMPARATOR
Intervention: Day hospital
Number of subjects: 0
Study 18424874 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both interventions
Number of subjects: 0
Study 17112374 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 1345
Study 17112374 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation with a GP who offers acupuncture
Number of subjects: 1345
Study 17112374 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation with a specialist
Number of subjects: 1345
Study 17112374 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic back pain
Number of subjects: 1345
Study 14768525 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 381
Study 14768525 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 381
Study 11155022 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture massage (APM)
Number of subjects: 109
Study 11155022 — intervention group
Group type: COMPARATOR
Intervention: Swedish massage (SM)
Number of subjects: 109
Study 11155022 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual medical exercises (IE)
Number of subjects: 109
Study 11155022 — intervention group
Group type: COMPARATOR
Intervention: Group exercises (GE)
Number of subjects: 109
Study 9096993 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatulin (30 mg) administered via intramuscular injections every 10 days for 9 months
Number of subjects: 9
Study 9096993 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injections every 10 days for 9 months
Number of subjects: 9
Study 1491545 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care for 30 patients living within an hour of the hospital for three months post discharge
Number of subjects: 163
Study 1491545 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care for 30 patients
Number of subjects: 163
Study 2883818 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 32
Study 2883818 — intervention group
Group type: COMPARATOR
Intervention: Flunitrazepam 2 mg
Number of subjects: 32
Study 31412056 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery practice (MIp): 15 minutes per day, 5 days per week in addition to routine physical therapy
Number of subjects: 34
Study 31412056 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery practice (MIp)
Number of subjects: 34
Study 31412056 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON): routine physical therapy alone
Number of subjects: 34
Study 30280915 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 120
Study 30280915 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Ball
Number of subjects: 120
Study 30280915 — intervention group
Group type: EXPERIMENTAL
Intervention: Video
Number of subjects: 120
Study 30280915 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 27295868 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental toothpaste containing 5% calcium sodium phosphosilicate (CSPS)
Number of subjects: 137
Study 27295868 — intervention group
Group type: COMPARATOR
Intervention: Abrasivity-matched placebo formulation (0% CSPS)
Number of subjects: 137
Study 27295868 — intervention group
Group type: COMPARATOR
Intervention: Commercially available fluoride toothpastes (controls)
Number of subjects: 137
Study 27295868 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentine Hypersensitivity Experience Questionnaire (DHEQ)
Number of subjects: 137
Study 24746570 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward planned field-in-field IMRT
Number of subjects: 815
Study 24746570 — intervention group
Group type: COMPARATOR
Intervention: Standard RT
Number of subjects: 815
Study 23185549 — intervention group
Group type: EXPERIMENTAL
Intervention: neoprene knee sleeve
Number of subjects: 31
Study 23185549 — intervention group
Group type: EXPERIMENTAL
Intervention: knee sleeve with four bilateral metal supports
Number of subjects: 31
Study 23185549 — intervention group
Group type: EXPERIMENTAL
Intervention: prophylactic knee brace
Number of subjects: 31
Study 23185549 — intervention group
Group type: COMPARATOR
Intervention: nonbraced (control)
Number of subjects: 31
Study 20965118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 95
Study 20965118 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 95
Study 20965118 — intervention group
Group type: COMPARATOR
Intervention: Guided Self-Help Group (GSG)
Number of subjects: 95
Study 17511229 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton-pump inhibitors (PPIs)
Number of subjects: 0
Study 17511229 — intervention group
Group type: COMPARATOR
Intervention: H2-receptor antagonists (H2RAs)
Number of subjects: 0
Study 17511229 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand treatment with H2RA
Number of subjects: 0
Study 16334718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and mild moxibustion
Number of subjects: 200
Study 16334718 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study 12456911 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide therapy (200 micro g twice a day)
Number of subjects: 183
Study 10480618 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetoacetate (AA) treatment in normal RBCs (37 degrees C for 24 h)
Number of subjects: 0
Study 10480618 — intervention group
Group type: COMPARATOR
Intervention: BHB treatment in normal RBCs
Number of subjects: 0
Study 10480618 — intervention group
Group type: COMPARATOR
Intervention: ACE treatment in normal RBCs
Number of subjects: 0
Study 10480618 — intervention group
Group type: COMPARATOR
Intervention: BHB presence with AA
Number of subjects: 0
Study 10480618 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E and N-acetylcysteine (NAC) as antioxidants
Number of subjects: 0
Study 10480618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperketonemic diabetic patients
Number of subjects: 0
Study 10480618 — intervention group
Group type: COMPARATOR
Intervention: Normoketonemic type 1 diabetic patients
Number of subjects: 0
Study 8729596 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus inhaler
Number of subjects: 159
Study 8729596 — intervention group
Group type: COMPARATOR
Intervention: Turbuhaler inhaler
Number of subjects: 159
Study 1365044 — intervention group
Group type: EXPERIMENTAL
Intervention: Pineal calcification (PC) on CT scan
Number of subjects: 0
Study 1365044 — intervention group
Group type: EXPERIMENTAL
Intervention: Disturbances of melatonin secretion
Number of subjects: 0
Study 7135289 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure, high-volume type of cuff
Number of subjects: 28
Study 7135289 — intervention group
Group type: COMPARATOR
Intervention: Traditional high-pressure, low-volume type of cuff
Number of subjects: 28
Study 31800067 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of β‐blockers
Number of subjects: 1761
Study 30043453 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalised periodontitis
Number of subjects: 804
Study 30043453 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-10 remaining teeth
Number of subjects: 804
Study 30043453 — intervention group
Group type: COMPARATOR
Intervention: ≥21 remaining teeth
Number of subjects: 804
Study 26477698 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 147
Study 26477698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 25140337 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled epidural catheters
Number of subjects: 121
Study 25140337 — intervention group
Group type: COMPARATOR
Intervention: Taped epidural catheters
Number of subjects: 121
Study 22203319 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3 mg/kg
Number of subjects: 23
Study 20004291 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (MLN)
Number of subjects: 195
Study 20004291 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (VLF)
Number of subjects: 195
Study 17175163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissureless technique
Number of subjects: 63
Study 17175163 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 63
Study 16356093 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithyroid drugs
Number of subjects: 179
Study 16356093 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine
Number of subjects: 179
Study 16356093 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 179
Study 16356093 — intervention group
Group type: EXPERIMENTAL
Intervention: Young medical patients (<35 years)
Number of subjects: 179
Study 16356093 — intervention group
Group type: EXPERIMENTAL
Intervention: Older surgical and radioiodine groups
Number of subjects: 179
Study 16356093 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 179
Study 16356093 — intervention group
Group type: COMPARATOR
Intervention: Young medical, young surgical, and older medical groups
Number of subjects: 179
Study 11895556 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg vaccine (Genhevac-B)
Number of subjects: 25
Study 11895556 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 20 microg vaccine (Genhevac-B) and 9 MU interferon alpha-2b (Roferon-A)
Number of subjects: 25
Study 9469336 — intervention group
Group type: EXPERIMENTAL
Intervention: r-metHu granulocyte colony-stimulating factor (G-CSF) during continuation therapy
Number of subjects: 89
Study 9469336 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G-CSF) during induction phase
Number of subjects: 89
Study 9469336 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G-CSF) during continuation therapy
Number of subjects: 89
Study 17214176 — intervention group
Group type: EXPERIMENTAL
Intervention: Human lymphoblastoid IFN alpha (Wellferon‐R) at a dosage of 5 MU, thrice weekly for 4 months
Number of subjects: 60
Study 17214176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 2193849 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1-s PRP
Number of subjects: 43
Study 2193849 — intervention group
Group type: COMPARATOR
Intervention: 0.5-s PRP
Number of subjects: 43
Study 763184 — intervention group
Group type: EXPERIMENTAL
Intervention: De-Nol
Number of subjects: 60
Study 763184 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine
Number of subjects: 60
Study 31058733 — intervention group
Group type: EXPERIMENTAL
Intervention: Altered scheduling of home care visits (n = 35)
Number of subjects: 67
Study 31058733 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group, n = 32)
Number of subjects: 67
Study 29070134 — intervention group
Group type: EXPERIMENTAL
Intervention: CDT+AC
Number of subjects: 139
Study 29070134 — intervention group
Group type: COMPARATOR
Intervention: AC
Number of subjects: 139
Study 25805811 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosaroxin
Number of subjects: 208
Study 25805811 — intervention group
Group type: COMPARATOR
Intervention: Low-dose Ara-C (LDAC)
Number of subjects: 208
Study 25805811 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosaroxin + LDAC
Number of subjects: 208
Study 24722949 — intervention group
Group type: EXPERIMENTAL
Intervention: Average static respiratory compliance over the first 14 days after diagnosis
Number of subjects: 82
Study 24722949 — intervention group
Group type: EXPERIMENTAL
Intervention: Average static respiratory compliance at day 14
Number of subjects: 82
Study 24722949 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial static respiratory compliance obtained within the first day after ARDS diagnosis
Number of subjects: 82
Study 23024438 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg melatonin nightly for 3 weeks
Number of subjects: 16
Study 23024438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19646075 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists' interventions in repeat prescribing, including a pharmacist's interview and annual medication data transfer to prescribing physician.
Number of subjects: 0
Study 19646075 — intervention group
Group type: COMPARATOR
Intervention: Normal repeat prescribing process (comparison group).
Number of subjects: 0
Study 19646075 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists' interventions in repeat prescribing.
Number of subjects: 0
Study 17544597 — intervention group
Group type: EXPERIMENTAL
Intervention: (125)I
Number of subjects: 164
Study 17544597 — intervention group
Group type: EXPERIMENTAL
Intervention: (103)Pd
Number of subjects: 164
Study 17544597 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant androgen deprivation therapy
Number of subjects: 164
Study 17544597 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <65 years
Number of subjects: 164
Study 17544597 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >=65 years
Number of subjects: 164
Study 14712425 — intervention group
Group type: EXPERIMENTAL
Intervention: Worsened renal function (creatinine level increase > or = 0.3 mg/dL) during HERS
Number of subjects: 2763
Study 14712425 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline creatinine levels from HERS
Number of subjects: 2763
Study 11252010 — intervention group
Group type: EXPERIMENTAL
Intervention: New combination regimens in phase II cancer clinical trials
Number of subjects: 0
Study 11252010 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study 11252010 — intervention group
Group type: COMPARATOR
Intervention: Proposed adjustment method for standard therapy outcomes
Number of subjects: 0
Study 11252010 — intervention group
Group type: EXPERIMENTAL
Intervention: Median survival estimation in confirmatory phase II trials
Number of subjects: 0
Study 11252010 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment method based on bootstrap resampling technique
Number of subjects: 0
Study 11252010 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation study
Number of subjects: 0
Study 9228378 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV) during sleep
Number of subjects: 21
Study 9228378 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 21
Study 8496534 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy administered to 55 patients 3.2 +/- 2.1 hours after the onset of symptoms.
Number of subjects: 104
Study 8496534 — intervention group
Group type: COMPARATOR
Intervention: Control group (49 patients) without thrombolytic therapy.
Number of subjects: 104
Study 3573270 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mL of autologous, previously frozen deglycerolized RBCs
Number of subjects: 6
Study 3573270 — intervention group
Group type: COMPARATOR
Intervention: 100 mL of saline solution
Number of subjects: 6
Study 29596102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 75 µg
Number of subjects: 64
Study 29596102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine 75 µg
Number of subjects: 64
Study 29596102 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 64
Study 27912953 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal mouthwash (Matricaria recutita and Mentha piperita), used three times daily for at least 30 seconds, starting one week before HSCT.
Number of subjects: 60
Study 27912953 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash, used three times daily for at least 30 seconds, starting one week before HSCT.
Number of subjects: 60
Study 25226824 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol consumption (1 drink or 15g/day) for 8 weeks
Number of subjects: 51
Study 25226824 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (2 drinks or 30g/day) for 8 weeks
Number of subjects: 51
Study 25226824 — intervention group
Group type: COMPARATOR
Intervention: No alcohol consumption
Number of subjects: 51
Study 23633746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention with a behavioral weight loss program
Number of subjects: 264
Study 23633746 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education
Number of subjects: 264
Study 20677584 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture and pharmacologic analgesia (acupuncture)
Number of subjects: 30
Study 20677584 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic analgesia alone (control)
Number of subjects: 30
Study 20677584 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 30
Study 20677584 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 18301905 — intervention group
Group type: EXPERIMENTAL
Intervention: BTX-A injection
Number of subjects: 74
Study 18301905 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (control)
Number of subjects: 74
Study 12585101 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuesaitong (XST) soft capsule
Number of subjects: 60
Study 12585101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 9817163 — intervention group
Group type: EXPERIMENTAL
Intervention: High molecular weight agents in powder form (two concentrations administered: half and double the one that caused a 20% fall in FEV1)
Number of subjects: 9